All Reporting
Walgreens Opioid Lawsuit Settled For $683 Million
MedTruth Editors · May 11, 2022
The state of Florida has reached a settlement with Walgreens over the drug store’s alleged role in contributing to the opioid epidemic.
Legal DevelopmentsFDA Approves Marketing of New Alzheimer's Test
MedTruth Editors · May 11, 2022
A new diagnostic test for Azlheimer's detection has been FDA-approved for marketing.
FDA RegulationVeteran Awarded $2.2 Million in 3M Earplug Trial
MedTruth Editors · May 10, 2022
This is 3M's ninth trial loss in 15 bellwether trials alleging that defective military earplugs cause hearing damage and tinnitus.
Legal DevelopmentsStudy Finds Limited PFAS Levels in Face Masks
MedTruth Editors · May 9, 2022
Researchers found eight of the nine masks tested did not exceed safe PFAS exposure levels.
Research + FindingsEthicon Loses $300 Million Surgical Mesh Appeal
MedTruth Editors · May 6, 2022
The company must pay over $300 million to California for misleading marketing practices regarding transvaginal mesh products.
Legal DevelopmentsFDA Proposes Flavored Tobacco Products Ban
MedTruth Editors · May 5, 2022
These bans have the potential to significantly decrease the rates of disease and death caused by burned tobacco products.
FDA RegulationBay Area Cities Sue Monsanto Over PCB Cleanup Costs
MedTruth Editors · May 4, 2022
Monsanto allegedly knew about the environmental and health hazards of PCBs but hid this information for its own profit.
NewsFake Covid Drug Manufacturers Face FDA Action
MedTruth Editors · May 3, 2022
These latest actions are part of a continued effort to crack down on unapproved, untested, or ineffective treatments for Covid-19 being sold to consumers.
FDA RegulationEPA Proposes Final Asbestos Ban
MedTruth Editors · April 29, 2022
The proposal would ban the importation of the last type of asbestos currently able to be brought into the US.
NewsFDA Proposes New Opioid Safety Initiative
MedTruth Editors · April 28, 2022
This new initiative would provide another avenue to traditional opioid disposal methods.
FDA RegulationGet our reporting in your inbox
Roundup Judge Criticizes Proposed False Advertising Settlement
MedTruth Editors · April 27, 2022
The settlement would provide payments to consumers who purchased certain Roundup products and resolve a lawsuit claiming that Monsanto failed to warn users.
Legal DevelopmentsFDA Authorizes First COVID-19 Breath Test
MedTruth Editors · April 26, 2022
This breath test provides highly accurate COVID-19 test results in a shorter timeframe than traditional PCR tests.
NewsJudge Denies 3M’s Fee Acceleration Motion For Earplug Plaintiffs
MedTruth Editors · April 22, 2022
3M argued that a court decision that waived the administrative docket’s $402 per claim filing fee has ballooned the number of defective earplug claims.
Legal DevelopmentsFDA Issues Cybersecurity Guidance For Medical Devices
MedTruth Editors · April 21, 2022
Attacks from cybercriminals have rendered entire hospital networks powerless and have led to delays in diagnosis, delays in treatment, and increases in patient harm.
FDA RegulationBayer Settles Dozens of Roundup Cancer Claims
MedTruth Editors · April 20, 2022
In March, Bayer announced that of approximately 138,000 cancer claims filed by individuals, 107,000 had been resolved or deemed ineligible.
Legal DevelopmentsOpioid MDL Growth Halted
MedTruth Editors · April 19, 2022
The window to join the massive MDL in Northern Ohio has been officially closed by the JPML.
Legal DevelopmentsSandoz Recalls Potentially Carcinogenic Muscle Pain Pills
MedTruth Editors · April 15, 2022
The recall affects 13 lots of the muscle pain and spasm drug Orphenadrine Citrate.
NewsFDA Rescinds Covid Drug Authorization
MedTruth Editors · April 14, 2022
Sotrovimab is an intravenous monoclonal antibody medication originally authorized for treating Covid-19.
FDA RegulationJudge Grants Fast-Track Appeal of J&J’s Talc Bankruptcy
MedTruth Editors · April 13, 2022
Judge Kaplan allowed plaintiffs who have alleged that J&J’s asbestos-contaminated talc products caused them to develop cancer to appeal his ruling
Legal DevelopmentsFDA Issues Warning to Unauthorized COVID Drug Makers
MedTruth Editors · April 12, 2022
Two companies that claim to make drugs that cure Covid-19 have been sent FDA warning letters.
FDA RegulationGet our reporting in your inbox
13th Military Earplug Trial Returns $50 Million Plaintiff Verdict
MedTruth Editors · April 8, 2022
The trial concluded that the military veteran developed hearing loss and severe tinnitus because of 3M’s negligence.
Legal DevelopmentsFDA Issues Rulings on E-Cigarette Products
MedTruth Editors · April 7, 2022
The FDA has been reviewing millions of E-cigarette products, approving ones that are likely to assist adult smokers looking to reduce or eliminate their combustible cigarette use.
FDA RegulationPfizer Recalls Blood Pressure Drug
MedTruth Editors · April 6, 2022
Pfizer detected a potentially carcinogenic compound in the blood pressure lowering drug Accuretic.
NewsAcrylamide Lawsuits Halted Over Inconclusive Cancer Claims
MedTruth Editors · March 31, 2022
The federal court ruled that there is not enough evidence proving that acrylamide, a substance that’s formed during the heating process of certain foods, causes cancer.
NewsBayer Brings Second Roundup Verdict Petition to Supreme Court
MedTruth Editors · March 30, 2022
The company behind Roundup weedkiller, which thousands claim caused their cancer, is petitioning the nation’s high court to review a Roundup case for the second time.
Legal DevelopmentsFDA Recalls Ventilators For Adhesive Defect
MedTruth Editors · March 29, 2022
Philips Respironics’ ventilators could stop functioning without warning or notification, potentially leading to patient deaths.
FDA RegulationLos Angeles Sues Monsanto Over PCBs in City Waterways
MedTruth Editors · March 25, 2022
Los Angeles is accusing Monsanto of failing to issue a warning to the city about the hazards PCBs.
NewsFDA Approves First Generic Version of Symbicort
MedTruth Editors · March 24, 2022
Generic drugs help to improve accessibility of affordable medicine. Generic Symbicort will provide greater options for treatment to those with asthma and COPD.
FDA RegulationJ&J Tested Asbestos On Inmates, Unsealed Docs Reveal
MedTruth Editors · March 23, 2022
The company hired a doctor to test the effects of asbestos on the inmates’ skin against the effects of talc.
NewsFDA Orders Phillips To Issue CPAP Warnings
MedTruth Editors · March 22, 2022
Some Philips CPAP and BiPAP machines use a foam that may break down and cause serious injury.
FDA RegulationGet our reporting in your inbox
Smith & Nephew Hip Implant MDL Claims Reduced
MedTruth Editors · March 18, 2022
Plaintiffs in the MDL all underwent hip resurfacing surgery with metal-on-metal implants.
Legal DevelopmentsJ&J Talc Bankruptcy Sparks Legislation Movement
MedTruth Editors · March 17, 2022
Attorneys and senators have come forth to suggest changes be made to the legislation surrounding bankruptcy law.
Laws + CongressChantix Carcinogen Class Action Dismissed
MedTruth Editors · March 16, 2022
The complaint accused Pfizer of misrepresenting the safety of the drug to consumers by failing to properly test Chantix despite warnings from regulators.
NewsNew Opioid Plan Increases Penalties for Sacklers
MedTruth Editors · March 15, 2022
A deal has been reached between the Sackler Family and the nine remaining states in the nationwide opioid settlement.
Legal DevelopmentsCook Medical IVC Filter Litigation Makes History in Indiana
MedTruth Editors · March 11, 2022
Retrievable IVC filters should be removed, but many are left in the body, and can cause bodily damage and pain.
NewsDrugmakers Lose Push to Pause Opioid Litigation
MedTruth Editors · March 10, 2022
Opioid litigation will continue after a judge rejected drug manufacturers' request for a pause.
Legal Developments3M Appeals First Military Earplug Trial Loss
MedTruth Editors · March 9, 2022
The company behind the military earplugs that allegedly cause hearing loss is urging the appeals court to bring an end to litigation.
Legal DevelopmentsBankruptcy Court Approves J&J Talc Case
MedTruth Editors · March 8, 2022
The judge is allowing Johnson & Johnson to move forward with the bankruptcy process for the company's new entity, LTL Management.
Legal DevelopmentsInvestors Predict 3M Financial Woes May Increase
MedTruth Editors · March 4, 2022
The current expected legal cost amounts to $33 billion. Analysts predict this number to be much higher for 3M.
NewsFDA Approves New Heart Disease Treatment
MedTruth Editors · March 3, 2022
This new heart medication adds another treatment option to reduce the risk of cardiovascular death and hospitalization due to heart failure.
FDA RegulationGet our reporting in your inbox
CA State Court Hears Zantac Lawsuits in October
MedTruth Editors · March 2, 2022
California will hold the first Zantac lawsuits in October of this year. Defendants are accused of failing to warn users about the drug's potential link to cancer.
Legal DevelopmentsBaby Formula Recalled by FDA
MedTruth Editors · March 1, 2022
Baby formula from a Michigan facility may be contaminated and has the potential to cause disease in infants.
NewsFDA Approves Generic Dry Eye Drug
MedTruth Editors · February 28, 2022
A generic form of Restasis has been FDA-approved for those suffering from dry eye. The drug increases the production of tears.
NewsFDA Recalls Fraudulent Covid Tests
MedTruth Editors · February 25, 2022
Two Covid tests labeled as FDA-approved have been recalled. The FDA recommends retesting with an authorized test and reporting any false results.
FDA RegulationVA Hearing Loss Bill Would Reduce Red Tape for Treatment
MedTruth Editors · February 22, 2022
The veteran has to prove that their damaged hearing was sustained during active duty, but many vets receive diagnoses after they have been discharged.
NewsTeva Settles Opioid Claims in Texas
MedTruth Editors · February 21, 2022
Teva will pay Texas $150 million in installments over the next 15 years to settle claims for the company's alleged role in the opioid epidemic.
NewsFDA Approves Veklury For Covid-19
MedTruth Editors · February 18, 2022
The FDA has approved a generic form of Remdesivir for the treatment of Covid in non-hospitalized patients.
NewsFDA Requests Public Comment on Credibility of Medical Device Models
MedTruth Editors · February 17, 2022
The new guidance will be used to support medical devices in the submission processes for a number of FDA approvals and clearances.
FDA Regulation$10 Million Eye Damage Lawsuit Joins Elmiron MDL
MedTruth Editors · February 16, 2022
Plaintiffs who allege that their vision has been damaged because of the drug all used Elmiron for many years.
Legal DevelopmentsJudge Blocks Discovery Request in Zantac Lawsuit
MedTruth Editors · February 15, 2022
GlaxoSmithKline will not be able to subpoena documents from plaintiffs in the Zantac multidistrict litigation.
Legal DevelopmentsGet our reporting in your inbox
Hernia Mesh Victims Move for MDL Consolidation
MedTruth Editors · February 11, 2022
Because the patients’ claims are nearly identical, it would be inefficient to have the same discovery processes repeated in multiple courts.
NewsOpioid Manufacturers Settle With Indigenous Tribes
MedTruth Editors · February 10, 2022
Indigenous tribes have reached a settlement with opioid manufacturers over their alleged role in the opioid crisis.
Legal Developments3M Blasted By $110 Million Military Earplug Verdict
MedTruth Editors · February 9, 2022
This award is the largest thus far in the largest federal mass tort in U.S. history.
Legal DevelopmentsJudge Declines To Decide Talc Committee’s Motions
MedTruth Editors · February 8, 2022
Judge Freda L. Wolfson has declined to decide issues arising from the bankruptcy of J&J’s subsidiary, LTL Management.
Legal DevelopmentsNew Mexico Receives $44 Million From J&J To Resolve Opioid Claims
MedTruth Editors · February 4, 2022
J&J will pay New Mexico for its role in fueling the opioid epidemic in the state.
NewsFDA Releases Patient Feedback Guidance
MedTruth Editors · February 3, 2022
The goal of these new guidances is to give patients and advocates a voice in the medical device process.
FDA RegulationSanofi Wins Taxotere Trial Over Hair Loss Claims
MedTruth Editors · February 2, 2022
Over 12,000 individuals allege that the breast cancer drug Taxotere caused their permanent hair loss, and that manufacturer Sanofi was aware that this could be a side effect of the drug.
Legal DevelopmentsFDA Recalls Medtronic Atherectomy Device
MedTruth Editors · February 1, 2022
Medtronic’s atherectomy system is a medical device used in surgical procedures to clear plaque from the walls of arteries that obstruct blood flow.
NewsRoundup Attorneys May Face Malpractice Claims For Failing to Produce Experts
MedTruth Editors · January 28, 2022
Judge Chhabria’s order stated that plaintiffs must produce an expert to support their claim that Roundup caused their non-Hodgkin's lymphoma.
Legal DevelopmentsFDA Recalls Anesthesia Component
MedTruth Editors · January 27, 2022
A flow anesthesia system provides inhaled anesthesia and controls the ventilation of patients with limited abilities to breathe.
NewsGet our reporting in your inbox
Supreme Court Asks Biden Admin To Weigh In on Roundup Appeal
MedTruth Editors · January 25, 2022
The U.S. Supreme Court asked the Solicitor General for the administration's views on the Roundup cancer trial that awarded plaintiff Edwin Hardeman $25 million.
Legal DevelopmentsFDA Releases Device Guidance Strategies For Women
MedTruth Editors · January 21, 2022
The CDRH Health of Women program aims to address the sex and gender disparity in medicine by including women in research and working to better understand their issues.
Women's HealthFDA-Approved COVID Testing Roundup
MedTruth Editors · January 20, 2022
The FDA has updated the Emergency Use Authorization clearance status of various different types of COVID-19 diagnostic tests.
FDA RegulationBayer Settles Boy's Roundup Rare Cancer Claims
MedTruth Editors · January 19, 2022
A mother claims her son developed Burkitt’s lymphoma from years of Roundup exposure.
Legal DevelopmentsDuPont Avoids PFAS Lawsuit in New York
MedTruth Editors · January 18, 2022
Suez Water New York claims DuPont contaminated New York’s water supply with PFAS.
Legal Developments3M Wins Ninth & Tenth Earplug Bellwether Trials
MedTruth Editors · January 14, 2022
The results of the latest 3M military earplug trials have gone in favor of manufacturer 3M, deeming the company not liable for two veterans' loss of hearing.
Legal DevelopmentsFDA Recalls Medtronic Ventilators After Complaints and Death
MedTruth Editors · January 13, 2022
The ventilators have an error that can cause the devices to stop working as intended and become inoperable, which can lead to neurological injury and, if left unchecked, death.
FDA RegulationPurdue Pharma Opioid Settlement Rejected By Judge
MedTruth Editors · January 12, 2022
Judge McMahon rejected the bankruptcy settlement plan that would have resolved thousands of opioid epidemic lawsuits against Purdue Pharma.
Legal DevelopmentsFDA Warns Medtronic Over Faulty Insulin Pumps
MedTruth Editors · January 11, 2022
In an inspection of Medtronic’s firm, the FDA found four major failures in the facility’s insulin pump manufacturing practices.
FDA RegulationE-Cigarette Direct Purchasers Fight Forced Arbitration
MedTruth Editors · January 6, 2022
The lawsuit alleges that Juul Labs sold a 35% share of its company to the Altria Group as part of a conspiracy to push Altria out of the e-cigarette marketplace in a bid for supremacy over e-cigarette prices.
Legal DevelopmentsGet our reporting in your inbox
Army Vet Awarded $22.5 Million in 3M Combat Earplugs Trial
MedTruth Editors · January 5, 2022
A federal jury in Florida found that 3M’s Combat Arms Earplugs were responsible for the Army vet’s hearing damage.
Legal DevelopmentsEthicon Attorneys Accuse Plaintiffs of Concealing Materials
MedTruth Editors · January 4, 2022
Attorneys for Ethicon told a New Jersey federal court that it needs access to marketing documents used by several lead-generation companies for attorneys.
Legal DevelopmentsWhistleblower Lawsuit Dismissed for Confidentiality Breach
MedTruth Editors · January 3, 2022
Two doctors claimed that the metal-on-metal hip implants of DePuy and J&J that were sold fell outside the FDA-approved manufacturing specifications.
Legal DevelopmentsStates Urge Federal Judge To Reject Purdue Pharma Settlement
MedTruth Editors · December 16, 2021
A group of U.S. states is urging a federal judge to reject a settlement that may benefit Oxycontin maker Purdue Pharma.
Legal DevelopmentsJ&J Talc Lawsuit Transfer to NJ Opens Suit to Dismissal
MedTruth Editors · December 15, 2021
After being transferred to New Jersey in November, J&J’s bankruptcy case may now meet fiercer resistance.
Legal DevelopmentsPlaintiffs in JUUL Lawsuit Thrown Out by Federal Judge
MedTruth Editors · December 14, 2021
The judge has thrown out 19 plaintiffs suing Juul Labs for injuries and deceitful marketing.
Legal DevelopmentsP&G Old Spice & Secret Products Recalled Over Benzene
MedTruth Editors · December 13, 2021
Old Spice men’s cologne and Secret deodorant aerosol cans were found to have detectable levels of benzene, a known human carcinogen that may cause cancer.
NewsParagard MDL Proceeds to Discovery
MedTruth Editors · December 10, 2021
The Paragard case will be moving forward after overcoming a motion to dismiss.
Legal DevelopmentsCancer Researchers Criticize Glyphosate Approval in the EU
MedTruth Editors · December 9, 2021
Europe’s leading cancer researchers are questioning the EU's decision to issue a positive safety review for glyphosate.
Research + FindingsOhio Jury Finds Pharmacies Liable For Opioid Crisis
MedTruth Editors · December 7, 2021
This verdict comes as an upset to a streak of losses that counties have suffered across the nation.
Legal DevelopmentsGet our reporting in your inbox
California Couple’s $86 Million Roundup Award Refused Review
MedTruth Editors · December 6, 2021
Bayer petitioned to review the outcome of the third Roundup trial that resulted in a damage award of $86 million.
Legal DevelopmentsJohnson & Johnson Settles Most Risperdal Lawsuits
MedTruth Editors · December 3, 2021
Thousands of lawsuits alleged that Risperdal, an anti-psychotic medication, caused them to develop enlarged breast tissue.
Legal DevelopmentsBaby Formula Lawsuits Filed Against Enfamil and Similac
MedTruth Editors · December 2, 2021
Premature infants were fed baby formulas Enfamil and Similac may develop a serious condition known as necrotizing enterocolitis (NEC).
NewsArmy Vet Awarded $13 Million in 3M Earplug Trial
MedTruth Editors · November 30, 2021
Guillermo Camarillorazo, a sergeant who served in Iraq and Afghanistan, was awarded $13 million.
Legal DevelopmentsTalc Advocates Reject J&J Settlement Talks
MedTruth Editors · November 29, 2021
Johnson & Johnson will most likely have to wait until at least 2022 before it can restart to negotiate a resolution.
Legal DevelopmentsNursing Home Outbreak Kills 8, Infects Dozens
MedTruth Editors · November 23, 2021
In a COVID outbreak at a nursing home in Connecticut, only three residents avoided infection.
NewsSupreme Court Throws Out Opioid Verdict
MedTruth Editors · November 18, 2021
The case accused Johnson & Johnson of creating a public nuisance with their opioid marketing that contributed to the opioid crisis
Legal DevelopmentsJ&J Allegedly Delaying Talc Trial in Mississippi
MedTruth Editors · November 17, 2021
Mississippi's Attorney General urged the Supreme Court to reject J&J's petition to delay the state’s seven-year talcum powder lawsuit.
Legal DevelopmentsProblematic KY Nursing Homes Profited From Pandemic Relief
MedTruth Editors · November 16, 2021
In Kentucky, some nursing homes profited from the pandemic even as their level of care decreased.
NewsGiant Eagle Resolves Ohio Opioid Suit During Trial
MedTruth Editors · November 12, 2021
The company agreed to settle lawsuits that accuse it of contributing to the opioid crisis in communities throughout Ohio.
Legal DevelopmentsGet our reporting in your inbox
Defendants Move For Paraquat MDL Dismissals
MedTruth Editors · November 11, 2021
Corporations Syngenta and Chevron USA are attempting to weed out invalid claims from the MDL.
Legal DevelopmentsOK Legislature Considers Revising Strict Opioid Law
MedTruth Editors · November 9, 2021
Oklahoma may roll back a Senate Bill that limits initial opioid prescription terms.
Laws + CongressPhilips Faces Class Action Suit Over Recalled Sleep Apnea Device
MedTruth Editors · November 8, 2021
Philips' CPAP machine was recalled in June over concerns that users could be exposed to polyester foam.
Legal DevelopmentsFDA Greenlights the First E-Cigarette Products for Sale
MedTruth Editors · November 5, 2021
The FDA has has authorized the first e-cigarette on the market, and it's not JUUL.
FDA RegulationElmiron Science Day Educates Judicial Officers
MedTruth Editors · November 4, 2021
Judicial officers were briefed on the mechanisms of Elmiron’s interaction with patients and the effects of long-term exposure linked to vision damage.
Legal DevelopmentsJudge Approves Investor Roundup Lawsuit Against Bayer
MedTruth Editors · November 3, 2021
Bayer failed to disclose the financial risks associated with the company’s 2018 acquisition of the Monsanto Corporation to its shareholders.
Legal DevelopmentsCOVID Burnout Takes a Toll on Social Workers
MedTruth Editors · November 2, 2021
Social workers dealing with opioid overdoses face an extra source of stress coming from the ongoing pandemic.
Health FeaturesEPA Launches Pesticide Investigation Councils
MedTruth Editors · November 1, 2021
The OCSPP Science Policy Council will monitor issues that arise within the pollution, toxics and pesticide sectors.
NewsPharmacies Accuse Gilead of Impeding Generic Drug Release
MedTruth Editors · October 27, 2021
CVS and Rite Aid are suing Gilead for suppressing the release of generic HIV drugs.
Legal DevelopmentsPatients Continue to Use Opioids 3 Months After Procedures
MedTruth Editors · October 26, 2021
A study found that 21% of patients continued to refill their opioid prescription three months to a year following their procedure.
Research + Findings